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The prevalence of diabetes in adult population in India has now 
reached alarming proportions with about 15 percent of those aged 
above 20 years in urban settings being diabetic.(1) Using similar 
diagnostic criteria (known diabetes and/or fasting and post-glucose 
load hyperglycaemia) the age-adjusted diabetes prevalence among 
adults in urban Chennai increased from 8.3% in 1988-89, to 11.6% 
(1994-95), 13.5% (2000) and 14.3% in 2003-04. Increase in diabetes 
prevalence has also been reported from rural Tamil Nadu.(2) Most 
diabetics remain unrecognized as a result of inadequate access to 
healthcare and screening programs and because they are not 
symptomatic until they have advanced stages of disease. A substantial 
proportion of those without overt diabetes has one or both of the pre-
diabetic states: Impaired fasting glucose and impaired glucose 
tolerance with risk of progression to diabetes.(3) With the emerging 
epidemic of diabetes in India, it is imperative to know if the pre-
admission diabetic status influences ICU outcomes, and if so further 
research would be warranted into management paradigms that will 
optimize outcomes.  
HbA1C expressed as a percentage of adult hemoglobin that is 
glycated, is the most widely used measure of chronic glycaemia. 
HbA1C assay that was introduced in the late 1970’s has become the 
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benchmark in assessing chronic glycaemia in research and the 
management of diabetes. Maintaining HbA1C within normal limits has 
been shown to reduce long term complications.(4) 
HBA1C reflects the average plasma glucose levels over the previous 
120 days which corresponds with the lifespan of an RBC. 
Standardized methods for estimating HBA1C is now readily available in 
most tertiary care facilities. Large studies have validated the 
correlation between mean plasma glucose levels in diabetics with 
HBA1C and have shown that HBA1C can be used to prognosticate 
outcomes in diabetics. (5) 
Patients in intensive care units frequently develop elevated blood 
sugars as a response to stress. Stressed Induced Hyperglycaemia 
(SIH) refers to a complex metabolic response to stress through raised 
catecholamines and stress hormones resulting in elevated blood sugar 
levels.(6) Intensive care experts recognize that this hyperglycaemia is 
associated with higher mortality. Patients requiring prolonged intensive 
care are at high risk for multiple organ failure and death. (7) 
Differentiating SIH from diabetic hyperglycaemia is challenging in the 
ICU setting in view of the universally elevated blood sugars.(8) HBA1C 
provides intensive care physicians a means to detect those with 
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diabetes and those at risk of developing diabetes in ICU settings and 
also helps to differentiate SIH from diabetics. 
Recently there is a divided opinion on how tight the glycaemic control 
in critically ill patients should be.(9-16) Several important issues 
contribute to the complexity of the understanding and preclude 
consensus on tight glycaemic control.(8) Initially it was believed that 
increased blood sugars are a coping response of the human body to 
acute stress and should not be controlled.(12) Subsequently it was 
postulated and supported by several coronary care and acute medical 
care setting studies that controlling blood sugars improved 
outcomes.(17)  Furthermore, glycaemic excursions have different 
effects in diabetic and non-diabetic individuals. A growing body of 
evidence that includes both SIH and diabetic hyperglycaemia suggests 
that these are different phenomena with different prognosis and needs 
to be approached differently.(18, 19).  
The 2010 American Diabetes Association guidelines incorporate 
HbA1C in the diagnosis of diabetes with values above 6.5% being 
diabetes and those between 5.7 and 6.4% as at risk of diabetes.(8) 
Risk stratification based on HbA1C will provide greater clarity into 
whether diabetics and those at risk of diabetes have poorer outcomes 
in critical care settings. We have not found other studies that examine 
the relationship between elevated HbA1C and ICU outcomes in trauma 
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patients. This study prognosticates the ICU stay among trauma 
patients on basis of their admission HbA1C. 
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Aims & Objectives 
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Aim:  
To evaluate if initial glycated hemoglobin (HbA1C) level in trauma 
patients predicts the outcome of patients admitted to Surgical Intensive 
Care Unit (SICU). 
Objectives:  
1) Estimate the prevalence of abnormal HbA1C levels in trauma 
patients irrespective of their admission glycaemic status.  
2) To explore the relationship between the initial HbA1C and the 
outcome of SICU admission among trauma patients. 
3) Estimate the correlation between the initial HbA1C level and the 
a)  duration of SICU stay  
b)  length of ventilated days  
c) and incidence of hospital acquired infections (HAI) among 
trauma patients admitted to SICU  
Hypothesis:  
Trauma patients with HbA1C levels above 6.0% will have a greater 
incidence of HAI, increased number of ventilated days, increased 
duration of stay in SICU and poorer outcomes in terms of mortality.
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Hyperglycaemia in hospitalized patients: (3) 
Three types of patients are described in literature with hyperglycaemia:  
 a) Hospital-related hyperglycaemia (Stress Induced Hyperglycaemia): 
hyperglycaemia occurring during the hospitalization that reverts to 
normal after hospital discharge.  
b)   Unrecognized diabetes: hyperglycaemia occurring during 
hospitalization and subsequently confirmed as diabetes after 
hospitalization but unrecognized as diabetes during the episode.  
c)        Medical history of diabetes: diabetes previously diagnosed and 
recognized by the treating physician. 
Hyperglycaemia in the hospital may result from stress and the body’s 
response to it; decompensation of type 1, type 2, or other forms of 
diabetes; and/or may be iatrogenic due to withholding of anti-
hyperglycaemia medications or administration of hyperglycaemia-
provoking agents such as glucocorticoids or vasopressors. (3) 
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Hospital related hyperglycaemia: 
In the mid-1800s, Reyboso observed glycosuria, a condition induced 
by ether anesthesia, in which glucose is discharged in the urine, and in 
1877 Claude Bernard described hyperglycemia during hemorrhagic 
shock.(7) Today, it is well known that any type of acute illness or injury 
results in insulin resistance, glucose intolerance, and hyperglycemia, a 
constellation termed “diabetes of injury”. (7) Illness or trauma 
increases hepatic glucose production with ongoing gluconeogenesis 
despite hyperglycemia and abundantly released insulin. Hepatic insulin 
resistance is further characterized by elevated circulating levels of 
Insulin like Growth Factor binding protein–1 (IGFBP-1). Glucose 
uptake in critically ill patients is increased but takes place mainly in the 
tissues that are not dependent on insulin for glucose uptake, such as, 
among others, the nervous system and the blood cells. 
Hyperglycaemia associated with critical illness is likely a consequence 
of many factors, including increased cortisol, catecholamines, 
glucagon, growth hormone, gluconeogenesis, and glycogenolysis.(6) 
Pro-inflammatory cytokines affect glucose homeostasis indirectly, by 
stimulating counter-regulatory hormone secretion, and directly, by 
altering insulin receptor signaling. (7) Insulin resistance may also be a 
contributing factor, since it has been demonstrated in more than 80 
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percent of critically ill patients.(6, 20) Various studies have shown that 
patients in the intensive care unit (ICU) commonly develop 
hyperglycaemia. (9, 13, 21) Hyperglycaemia was previously 
considered an adaptive response essential for survival and was not 
routinely controlled in intensive care units. (21, 22) However, more 
recent evidence indicating that uncontrolled hyperglycaemia is 
associated with poor outcomes has prompted efforts to routinely 
correct and prevent hyperglycaemia in critically ill patients. Patients 
who are hyperglycaemic following trauma have an admission 
preoperative glucose which is predictive of morbidity mortality rate, 
length of hospital stay, length of ICU stay, and incidence of nosocomial 
infection. (9, 12, 13, 16, 23-25)  
Hyperglycaemia is also associated with poorer neurologic outcomes 
and increased intracranial pressure in patients with traumatic brain 
injury.(26) In a retrospective cohort study of 77 patients with severe 
traumatic brain injury, hyperglycaemia (blood glucose ≥170 mg/dl ) at 
the time of ICU admission was an independent predictor of a poor 
Glasgow coma score five days later.(26, 27)  Whether SIH per se 
causes harm or, instead, is a marker of severity of counter-regulatory 
hormone release, inflammatory response, and degree of illness is 
unknown. 
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Occult diabetes mellitus diagnosed based on an HbA1C level in trauma 
patients was found to be as high as 22%.(28) The presence of 
diabetes not diagnosed prior to hospitalization necessitates 
differentiating diabetes from SIH. In the ICU setting this is challenging. 
Recent literature suggests that SIH and diabetic hyperglycaemia are 
not the same; SIH, compared with diabetic hyperglycaemia, seems to 
have a higher risk for adverse outcomes in hospitalized patients, 
including an increased risk of in-hospital mortality and longer duration 
of stay. (29-31) Identifying pre diabetes in patients who are critically ill 
using conventional blood sugar estimation is inappropriate as stress 
response causes an increase in the blood sugars. Pre diabetics are 
those patients who have either impaired glucose tolerance or have an 
impaired fasting glucose. Impaired glucose tolerance is defined by the 
ADA as a fasting plasma glucose of <126mg/dl or a two hour post 
prandial plasma glucose between 140 to 200mg/dl. Impaired fasting 
glucose is defined as a fasting glucose between 110mg/dl and 
126mg/dl and a two hour post prandial glucose of >140mg/dl. HbA1C, 
a marker of glycaemic control for the preceding 3 months, is now 
endorsed by the American Diabetes Association for diabetic 
screening.(8) HbA1C is currently the only tool available for 
differentiation once the patients are critically ill and may be appropriate 
for risk stratification. The A1C–Derived Average Glucose Study data 
demonstrate that hemoglobin A1C levels of 6.0% and 7.0% equal 
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average glucose levels of 126 and 154 mg/dl, respectively.(32) The 
2010 American Diabetic Association standards for medical 
management of diabetes incorporate HbA1C as diagnostic modality 
alongside FPG and IGT. HbA1C less than 5.7 is considered normal, 
between 5.7 and 6.4 at risk for diabetes and those with HbA1C 6.5 or 
more is diagnostic of diabetes.(8) Further studies of A1C in critically ill 
patients could potentially validate these numbers for risk-stratification 
purposes.(33) 
Glycaemic control in critically ill: 
While the management of hyperglycaemia in the hospital has logically 
been considered secondary in importance to the condition that 
prompted admission, a body of literature now supports targeted 
glucose control in the hospital setting for potential improved clinical 
outcomes.(14) There is substantial observational evidence linking 
hyperglycaemia in hospitalized patients (with or without diabetes) to 
poor outcomes.(12, 13, 34, 35)  
A few early randomized controlled trials and observational cohort 
studies suggested that intensive treatment of hyperglycaemia improved 
hospital outcomes.(11, 15, 36) Van den Berg et al, reported a 42% 
relative reduction in intensive care unit (ICU) mortality in critically ill 
surgical patients treated to a target blood glucose of 80 –110 
mg/dl.(11) 
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 Interventions for glycaemic control, however, have had inconsistent 
results. Recent trials in critically ill patients have failed to show a 
significant improvement in mortality with intensive glycaemic control 
(10, 37) or have even shown increased mortality risk.(13) Moreover, 
these recent RCTs have highlighted the risk of severe hypoglycaemia 
resulting from such efforts. (10, 13, 37, 38) 
NICE-SUGAR, a large multicenter, multinational RCT, tested the effect 
of tight glycaemic control (target 81–108 mg/dl) as opposed to 
conventional glycaemic control (target 144–180 mg/dl) on outcomes 
among 6,104 critically ill participants, the majority of who required 
mechanical ventilation.(13) Ninety-day mortality was significantly higher 
in the intensive versus the conventional group (78 excess deaths; 27.5 
vs. 24.9%, P 0.02) in both surgical and medical patients. Severe 
hypoglycaemia was also more common in the intensively treated group 
(6.8 vs. 0.5%; P < 0.001). The precise reason for the increased 
mortality in the tightly controlled group is unknown. It must be noted 
however that the control group in NICE-SUGAR had reasonably good 
blood glucose management, maintained at a mean glucose of 144 
mg/dl and might explain partially the good outcomes in the control arm 
and does not detract from the notion that glycaemic control in the ICU 
is important. The conclusions of the NICE study suggest that it a highly 
stringent target of < 110 mg/dl actually may be dangerous. 
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Griesdale et al, in a meta-analysis of 26 trials (N = 13,567), which 
included the NICE-SUGAR data report that the pooled relative risk 
(RR) of death with intensive insulin therapy was 0.93 as compared with 
conventional therapy (95% CI 0.83–1.04). Patients in surgical ICUs 
appeared to benefit from intensive insulin therapy (RR 0.63 [95% CI 
0.44–0.91]), while those in other critical care settings did not (medical 
ICU: 1.0 [0.78 –1.28].(12) 
 In its consensus statement on standards for medical care of diabetes 
2010, the American Diabetes Association states, “It is very clear that 
the management of hyperglycaemia in the hospital presents unique 
challenges. Accordingly, reasonable glucose targets in the hospital 
setting are modestly higher than may be routinely advised in patients 
with diabetes in the outpatient setting.” “Based on the weight of the 
available evidence, for the majority of critically ill patients in the ICU 
setting, insulin infusion should be used to control hyperglycaemia, with 
a starting threshold of >180 mg/dl. Once intravenous insulin is started, 
the glucose level should be maintained between 140 and 180 mg/dl. 
Greater benefit may be realized at the lower end of this range.” (8) 
There is evidence to suggest that in-hospital hyperglycaemia is 
associated with adverse outcomes. A meta-analysis of 14 studies has 
shown that hyperglycaemia (blood glucose >140 mg/dL) with or without 
a prior diagnosis of diabetes increased both in-hospital mortality and 
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congestive heart failure (CHF) in patients admitted for acute myocardial 
infarction. (39) Similar data were reported in a prospective study of 336 
patients. Hyperglycaemia (fasting blood glucose >126 mg/dL, random 
blood glucose >200 mg/dL  in general medical and surgical units was 
associated with an 18-fold increase in in-hospital mortality, a longer 
length of stay , more subsequent nursing home care, and a greater risk 
of infection. (30) 
Diabetes and Surgery: 
The incidence of peri-operative morbidity and mortality among diabetic 
patients is higher when compared to non-diabetics (40) but better 
monitoring and control of peri-operative blood glucose have shown to 
be beneficial. (41)  
Glycated Haemoglobin: (42) 
Glycated Haemoglobin (HbA1C) is a term used to describe a series of 
stable minor Haemoglobin components formed slowly from 
Haemoglobin and glucose. The rate of formation of HbA1C is directly 
proportional to the glucose concentration. (43, 44) Since erythrocytes, 
with a life-span of 120 days, are freely permeable to glucose, the level 
of HbA1c in a blood sample provides a glycaemic history of the 
previous 2-3 months. Laboratory measurement of HbA1C became 
available in the late 1970s.(4) 
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HbA1c is formed non-enzymatically by haemoglobin's exposure to 
plasma glucose. This simple reaction proceeds in two stages (Fig 1).  
1. Glucose combines with the amino group of the valine residue at the 
N-terminus of 18 goblin chains to form an aldimine compound (Schiff 
base). This reaction is reversible, and dissociation back to 
Haemoglobin and glucose can occur readily. 
 2. Internal rearrangement of the aldimine intermediate by the amadori 
reaction yields a stable ketoamine derivative, which is irreversible. 
 
Figure 1 - HBA1C formation 
Glycosylation begins during erythropoiesis and continues slowly 
throughout the lifespan of the circulating Haemoglobin. 
As each erythrocyte circulates for 120 days, there is opportunity for late 
maillard reactions or non-enzymatic browning to occur (the products of 
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these reactions are referred to as Advanced Glycation End products 
[AGE]) and the extent of these changes appear to correlate with the 
level of HbA1c. In connective tissues and vascular endothelium, AGEs 
may be important mediators of diabetes pathology as well as the 
normal aging process. AGE accumulate in diabetes as a result of 
hyperglycaemia, leading to glycosylation of collagen. This process 
results in abnormal collagen, which is highly inflexible and prone to 
breakdown, particularly over pressure areas. Research has shown that 
several biochemical pathways associated with hyperglycaemia, 
including glucose auto-oxidation, polyol pathway, prostanial synthesis, 
and protein glycation can increase the production of free radicals. (44) 
Free radicals generated by the auto-oxidation reactions of sugar and 
sugar attached to protein are possible sources of oxidation stress and 
damage to protein in patients with diabetes. Glyco-oxidation products 
accumulate in collagen at an accelerated rate in patients with 
diabetes.(45)  This oxidative stress leads to complications in diabetes, 
such as tissue damage and cell death, which are reversed by 
antioxidants. Renal and hepatic diseases, haemolytic anemia and 
haemoglobinopathies shorten red cell survival and therefore the period 
of exposure to glucose, leading to a decrease in HbA1C.(8) 
High Performance Liquid Chromatography (HPLC) methods often used 
as “reference method” for the standardisation of routine tests provide 
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good precision and long-term stability but they are rather unspecific. 
Different values for HbA1C can be obtained when the same blood 
samples are measured, depending on the chromatographic system, 
e.g. the kind of resin, lot-to-lot variation of resins, column size, buffer 
composition and elution times. (42) 
In the first step Haemoglobin is cleaved into peptides by the proteolytic 
enzyme endoproteinase Glu-C. Thereafter the resulting glycated and 
non-glycated N-terminal hexapeptides of the β-chains are separated 
from the crude peptide mixture and quantified by HPLC and 
electrospray mass spectrometry or by HPLC followed by capillary 
electrophoresis with UV detection. The percentage of HbA1c is 
determined as a ratio of the glycated to non-glycated β -N-terminal 
hexapeptides of Haemoglobin. (42) 
Hennesse et al investigated the interaction of blood glucose 
concentration and wound collagen glycosylation, collagen content, and 
proteolytic activity during wound healing in diabetic rats. They showed 
that long term hyperglycaemia leads to the formation of AGE, which 
contributes to many of the complications of diabetes. The amount of 
AGE is proportional to the duration of diabetes. AGE leads to abnormal 
cross linking causing increased phagocytosis of the affected proteins 
and protein catabolism. This increased catabolism of structurally 
 Page | 20  
 
abnormal proteins in uncontrolled diabetic patients leads to impairment 
of wound healing. (46) 
One percent increase in glycated Haemoglobin has been shown to be 
associated with 18% increase in the risk for coronary heart disease or 
stroke and a 28% increase in the risk for peripheral vascular disease. 
(47) These data highlight the utility of the glycated Haemoglobin level 
as a measure of risk for cardiovascular events in type 2 diabetes. 
Khaw et al correlated the level of HbA1C to the incidence of 
cardiovascular events. They demonstrated a 21% increase in 
cardiovascular events for every 1% increase in HbA1C level above 5%. 
They also concluded that HbA1C level of 6.59% in a non-diabetic 
predicts a higher cardiovascular risk than an HbA1C level of 5.5% in a 
well-controlled diabetic. (48) These two studies (47, 48) have clearly 
proved that the glycated Haemoglobin level is an independent risk 
factor for cardiovascular events, regardless of diabetes status. 
Latham et al analyzed 300 diabetic patients undergoing cardiac 
surgery and compared wound infection in patients with HbA1C greater 
and less than 8%. They concluded that elevated HbA1C was not 
associated with statistically significant increase risk of infection. 
However, the poorly controlled diabetics had significantly higher levels 
of blood glucose in the post-operative period. (49) 
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Dronge et al did a retrospective observational study on the relationship 
of long-term glycaemic control and post-operative infection in 490 
diabetics. Oral treatment was the main form of diabetic therapy 
(59.0%). The HbA1c levels ranged from 4.6% to 15.5% (median - 
7.3%). The incidence of infection in patients with HbA1C <7% was 12% 
while it was 20% in those with HbA1C > 7%.(50) They concluded that 
good pre-operative glycaemic control (HbA1C below 7%) reduces post-
operative infections following a variety of surgical procedures. 
Prospective studies indicate that people within the HbA1C range of 
5.5–6.0% have a 5-year cumulative incidence of diabetes that ranges 
from 12 to 25% (17, 49, 51), which is appreciably (three- to eightfold) 
higher than incidence in the population as a whole (52). HbA1C range 
of 5.7 to 6.4% can be used to identify individuals with high risk for 
future diabetes and these patients are called as pre diabetics. 
Individuals with an HbA1C of 5.7–6.4% should be informed of their 
increased risk for diabetes as well as cardiovascular disease and 
counseled about effective strategies, such as weight loss and physical 
activity, to lower their risks. As with glucose measurements, the 
continuum of risk is curvilinear, so that as HbA1C rises, the risk of 
diabetes rises disproportionately. As recommended by the American 
Diabetic Association interventions should be most intensive and follow-
up should be particularly vigilant for those with HbA1C levels above 
 Page | 22  
 
6.0%, who should be considered to be at very high risk. An HbA1c 
level of >6.5% is diagnostic of diabetes mellitus. Epidemiologic 
datasets show a relationship between A1C and the risk of retinopathy 
similar to that which has been shown for corresponding Fasting Plasma 
Glucose (FPG) and 2-h Post Prandial Glucose (PPG) thresholds. The 
HbA1C has several advantages to the FPG, including greater 
convenience, since fasting is not required; evidence to suggest greater 
pre-analytical stability; and less day-to-day perturbations during periods 
of stress and illness. 
STUDY No. of 
patients 
Outcome studied HbA1C 
cut off 
level 
result 
Hennesse 
et al 
(1990) 
- Wound healing in 
diabetic rats 
- Uncontrolled 
diabetes impaired 
wound healing 
Khaw et al  
(2004) 
Men – 
4662 
Women - 
5570 
Risk of 
cardiovascular 
disease in relation 
to HbA1C level 
- Risk of 
cardiovascular 
disease increases 
with an increase in 
HbA1C level 
Latham et 
al 
(2001) 
300 Wound healing in 
Diabetic patients 
undergoing 
cardiac surgery 
8% No statistical 
significant 
difference between 
the two groups 
Dronge et 
al (2006) 
480 Postoperative 
infection in 
diabetic patients 
7% 8% more infection 
in patients with a 
HbA1C >7% 
Table 1 - Studies on HBA1C  
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Diabetes and Hospital Acquired Infection (HAI): 
A diabetic patient is at greater risk during the post-operative period to 
systemic and surgical site infection and they are also prone to 
metabolic decompensation, such as fluctuating blood glucose levels 
and keto-acidosis. The association between hyperglycaemia and the 
susceptibility to Hospital Acquired Infection is multi-factorial. 
i) Hyperglycaemia has been shown to impair the normal functions of 
the neutrophils, which include adherence, chemotaxis, phagocytosis 
and intracellular bactericidal activity. The degree of neutrophil 
impairment correlates with the degree of hyperglycaemia. The glucose 
level threshold for neutrophil dysfunction is 200 mg/dL (range - 130-
275 mg/dL). (53)  
ii) Hyperglycaemia alters vascular permeability and the normal redox 
reactions which creates a state of pseudo-hypoxia and impaired tissue 
defenses. Elevated tissue levels of glucose and the formation of edema 
due to the increased vascular permeability, promotes bacterial growth. 
(53) 
iii) Micro and macro-vascular manifestations of diabetes may disrupt 
supply of nutrients, oxygen, leukocytes and antibiotics to the operated 
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site leading to impaired wound healing. Oxygen is necessary for 
macrophage mobility and growth of granulation tissue. (53) 
iv) In patients with diabetic neuropathy, disruption of the skin may go 
undetected which can form a portal for entry of the bacteria. (53) 
v) Glucose is a pro-inflammatory mediator that has been shown to 
stimulate cytokine production and inhibit endothelial nitric oxide levels. 
Insulin enhances the ability of cytotoxic lymphocytes to attack target 
cells. Therefore, insulin deficiency makes the diabetic patients more 
susceptible to infection. 
vi) The bone marrow-derived endothelial progenitor cell is vital in 
vasculogenesis and wound healing, but their numbers are decreased 
in diabetes due to impaired activity of endothelial derived nitric oxide 
synthetase. Poor healing of diabetic wounds is characterized by 
impaired angiogenesis and vasculogenesis. Control of blood sugar 
level also retards the progression of vascular complications. 
Latham et al studied the association of glucose control with surgical 
site infections among patients undergoing cardio-thoracic surgery. In a 
prospective cohort and case-control study, to assess the importance of 
diabetes, diabetes control, hyperglycaemia, and previously 
undiagnosed diabetes in the development of surgical-site infections. 
They found that presence of diabetes and post-operative 
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hyperglycaemia was independently associated with development of 
surgical site infection. (49) 
Carson, et al did a retrospective cohort study to determine the impact 
of diabetes mellitus on short-term mortality and morbidity in patients 
undergoing coronary artery bypass surgery. They found that the 30-day 
mortality was 3.7% in patients with diabetes and 2.7% in those without. 
Morbidity, infections and the composite outcomes occurred more 
commonly in diabetic patients and were associated with a risk about 
35% higher in diabetics than in non-diabetics. They concluded that 
diabetes is an important risk factor for mortality and morbidity among 
those undergoing coronary artery bypass surgery. (40) 
Bhatia et al did a prospective study to evaluate the risk factors for 
postoperative wound infection in 615 patients undergoing coronary 
artery bypass graft surgery, of whom 269 (43%) were diabetic. 116 
(18.86%) patients developed infection of the surgical sites involving 
sternum (75%), leg (21.3%) and forearm (3.44%).  Sternal site, obesity, 
diabetes mellitus and female gender were associated with significantly 
higher infection rates. Diabetes, especially uncontrolled, was a 
significant risk factor for the development of surgical site infection. (54) 
Golden et al studied the peri-operative glycaemic control and the risk of 
infections complications in 411 diabetics, who underwent coronary 
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artery surgery. Peri-operative glycaemic control was assessed by the 
average of six capillary glucose measurements taken during the 36 
hour following surgery. The major outcomes studied were infections of 
the leg and the chest wounds, pneumonia and urinary tract infection. 
They found that patients with higher mean capillary glucose readings 
were at increased risk of developing infections compared with those 
with the low post-operative glucose levels. They concluded that in 
diabetics who undergo coronary artery surgery, hyperglycaemia is an 
independent predictor of short-term infections in the post-operative 
period, and the physician should consider a glucose concentration 
target of <200 mg.dL-1 to reduce the risk of infection. (53) 
Nosocomial Infections: (55, 56) 
A nosocomial infection is a localized or systemic condition 1) that 
results from adverse reaction to the presence of an infectious agent 2) 
that was not present or incubating at the time of admission to the 
hospital. (55, 56)For most bacterial nosocomial infections, this means 
that the infection usually becomes evident 48 hours or more after 
admission 
URINARY TRACT INFECTION:  
Symptomatic urinary tract Infection should meet one of the following 
criteria: 
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Criterion 1: Patient has at least one of the following signs or symptoms 
with no other recognized cause: fever (>38° C), urgency, frequency, 
dysuria, or supra-pubic tenderness and patient has a positive urine 
culture, that is, 105 microorganisms per cm3 or urine with no more than 
two species of microorganisms. 
Criterion 2: Patient has at least two of the following signs or symptoms 
with no other recognized cause: fever (>38° C), urgency, frequency, 
dysuria, or supra-pubic tenderness and at least one of the following: 
a. positive dipstick for leukocyte esterase and/or nitrate 
b. Pyuria (urine specimen with 10 wbc/mm3 or 3 wbc/high power 
field of unspun urine) 
c. organisms seen on Gram stain of unspun urine 
d. at least two urine cultures with repeated isolation of the same 
uropathogen (gram-negative bacteria or S. saprophyticus) with 
102 colonies/ml in non-voided specimens 
e. 105 colonies/ml of a single uropathogen (gram-negative bacteria 
or S. saprophyticus) in a patient being treated with an effective 
antimicrobial agent for a urinary tract infection 
f. physician diagnosis of a urinary tract infection 
g. physician institutes appropriate therapy for a urinary tract 
infection. 
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An asymptomatic bacteruria must meet at least one of the following 
criteria: 
Criterion 1: Patient has had an indwelling urinary catheter within 7 days 
before the culture 
And patient has a positive urine culture, that is, 105 microorganisms per 
cm3 of urine with no more than two species of microorganisms and 
patient has no fever (>38° C), urgency, frequency, dysuria, or supra-
pubic tenderness. 
Criterion 2: Patient has not had an indwelling urinary catheter within 7 
days before the first positive culture and patient has had a least two 
positive urine cultures, that is, 105 microorganisms per cm3 of urine 
with repeated isolation of the same microorganism and no more than 
two species of microorganisms and patient has no fever (>38° C), 
urgency, frequency, dysuria, or supra-pubic tenderness. 
SURGICAL SITE INFECTION (Superficial incision) 
DEFINITION: A superficial SSI must meet the following criterion: 
Infection occurs within 30 days after the operative procedure and 
involves only skin and subcutaneous tissue of the incision and patient 
has at least one of the following: 
a. purulent draining from the superficial incision 
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b. organisms isolated from an aseptically obtained culture of fluid 
or tissue from the superficial incision 
c. at least one of the following signs or symptoms of infection: pain 
or tenderness, localized swelling, redness, or heat, and superficial 
incision is deliberately opened by surgeon, unless incision is culture-
negative 
SURGICAL SITE INFECTION (Deep incision) 
DEFINITION: A deep incision SSI must meet the following criterion:  
Infection occurs within 30 days after the operative procedure if no 
implant is left in place or within one year if implant is in place and the 
infection appears to be related to the operative procedure and involves 
deep soft tissues (e.g., fascial and muscle layers) of the incision and 
patient has at least one of the following: 
a. purulent drainage from the deep incision but not from the 
organ/space component of the surgical site 
b. a deep incision spontaneously dehisces or is deliberately 
opened by a surgeon when the patient has at least one of the following 
signs or symptoms: fever (>38° C), or localized pain or tenderness, 
unless incision is culture-negative 
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c. an abscess or other evidence of infection involving the deep 
incision is found on direct examination, during reoperation, or by histo-
pathologic or radiologic examination 
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BLOODSTREAM INFECTION 
Laboratory-confirmed bloodstream infection must meet at least one of 
the following Criteria: 
Criterion 1: Patient has a recognized pathogen cultured from one or 
more blood cultures and organism cultured from blood is not related to 
an infection at another site. 
Criterion 2: Patient has at least one of the following signs or symptoms: 
fever (>38° C), chills, or hypotension and at least one of the following: 
a. common skin contaminant (e.g., diphtheroids, Bacillus sp., 
Propionibacterium sp., coagulase-negative staphylococci, or 
micrococci) is cultured from two or more blood cultures drawn on 
separate occasions 
b. common skin contaminant (e.g., diphtheroids, Bacillus sp., 
Propionibacterium sp., coagulase-negative staphylococci, or 
micrococci) is cultured from at least one blood culture from a patient 
with an intravascular line, and the physician institutes appropriate 
antimicrobial therapy 
c. Positive antigen test on blood (e.g., H. influenzae, S. 
pneumoniae, N. meningitidis, or group B Streptococcus) and signs and 
symptoms and positive laboratory results are not related to an infection 
at another site. 
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Ventilator Associated Pneumonia 
 Ventilator-associated bacterial pneumonia (VAP) is a major threat to 
the recovery of patients receiving mechanical ventilation, and is one of 
the most important intensive care unit (ICU)-acquired infections in 
mechanically ventilated patients. The European Prevalence of Infection 
in Intensive Care (EPIC) study found that VAP was the most common 
Hospital Acquired Infection accounting for up to 45% of all infections in 
the ICU. The Clinical Pulmonary Infection Score (CPIS), a diagnostic 
algorithm for the diagnosis of VAP that relies on easily available 
clinical, radiographic, and microbiological criteria. A CPIS of 6 or more 
is diagnostic of a VAP.  
CPIS Points 0 1 2 
Tracheal secretions Rare Abundant Abundant + purulent 
Chest X-ray infiltrates No infiltrate Diffused Localized 
Temperature, °C 36.5 and 38.4 
38.5 and 
38.9 39 or 36 
Leukocytes count, per 
mm3 
4,000 and 
11,000 
< 4,000 or > 
11,000 
< 4,000 or > 
11,000 & band 
forms 500 
PAO2/FIO2, mm Hg 
> 240 or 
ARDS  
240 and no 
evidence of 
ARDS 
Microbiology Negative Positive 
 
Table 2 CPIS SCORING SYSTEM 
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APACHE II SCORE(57) 
APACHE II – Acute Physiology and Chronic Health Evaluation System 
is a severity of disease classification which was first validated and used 
by Knaus W A et al and published in the Critical Care Medicine Journal 
in 1985.(57) APACHE II uses a point score based upon initial values of 
12 routine physiologic measurements, age, and previous health status 
to provide a general measure of severity of disease. (Appendix 1)The 
physiological measurements include the temperature, mean arterial 
pressure, heart rate, respiratory rate, oxygenation, arterial pH, serum 
sodium levels, serum potassium level, serum creatinine (with or without 
acute renal failure), haematocrit, the total count and the Glasgow 
Coma Score. (Appendix 1). The score ranges from 0 to 71 with a 
worsening outcome as the score rises. When APACHE II scores are 
combined with an accurate description of disease, it can be used to 
prognosticate acutely ill patients and will also guide investigators to 
compare new modes of treatment. Another use of the APACHE II score 
is that it can be used to evaluate the use of hospital resources and 
compare between intensive care units as to the efficacy of care. 
APACHE II has been used universally in many clinical trials since it 
provides a consistency between different groups. An objective scoring 
system such as the APACHE II score, allows audits of different units or 
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the same unit with historical controls, and comparisons of different 
treatment modalities in those with similar severity of illnesses. In the 
current environment of escalating medical costs the APACHE II scores 
may allow us to restrict intensive care to those most at need, and 
provide a gauge of illness for deciding how aggressive management 
should be.   The popularity in the use of the APACHE II score is that it 
is simple to use and there is available software to simplify analysis. 
INJURY SEVERITY SCORE (58, 59) 
It is a scoring system that is used to simplify complex and variable 
patient data to a single number. In this process some amount of 
accuracy and information is lost. Abbreviated Injury Score – Is an 
anatomical scoring that was first introduced in 1969 with multiple 
revisions since, the latest on being in 1998.(59) Injuries are graded on 
a scale from 1 to 6 as shown in the following table 3.  
INJURY AIS Score 
1 minor 
2 Moderate 
3 Serious 
4 Severe 
5 Critical 
6 Un-survivable 
 
Table 3 - Injury Severity Score 
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The injury severity score is an anatomical scoring system that uses the 
AIS in its calculation. The body is divided into six regions and the 
respective AIS are calculated. The 3 most severely injured body 
regions have their score squared and added together to produce the 
ISS score. The ISS score ranges from a minimum score of 0 to a 
maximum of 75. If an injury is assigned an AIS of 6 (un-survivable 
injury), the ISS score is automatically assigned to 75.The ISS score 
relates well with the mortality, morbidity and the hospital stay. The draw 
backs in the ISS are that a small error in the AIS scoring increases the 
corresponding error in the calculated ISS and different injury patterns 
can yield the same ISS score and injuries to different body regions are 
not weighted.   
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Patients & Methods 
 Page | 37  
 
 
Settings: 
The study was done in the Surgical Intensive Care Unit (SICU) of 
Christian Medical College Hospital, Vellore which is a 2000 bedded 
tertiary care hospital serving about 90,000 inpatients and 1.5 million 
outpatients annually. Tight glycaemic control in SICU patients is done 
to maintain the blood sugar level between 80 to 120 mg/ dl.  
Control of sugars in the SICU is done following a sliding scale. When 
sugars are abnormal the following algorithm is used. The algorithm is 
explained in appendix 2. 
 
Insulin is given as an infusion with the help of a syringe pump which 
contains 20 units of short acting insulin in 20 ml of normal saline. 
Insulin infusion is started when there are more than two blood sugars 
values of greater than 120mg/dl. Blood sugars are checked every four 
Algorithm Category of patients 
I Non Diabetic 
II Diabetics, Hypertensives and Patients on TPN 
III Uncontrolled Diabetics on Total Parenteral Nutrition  
IV Uncontrolled diabetics 
Table 4 - Insulin algorithm  
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hours on a routine basis and in some cases every one hour till 
appropriate control of sugars is achieved.  
Inclusion criteria: 
1. Age more than 16 years 
2. All trauma patients who came to the operation theatre and required 
post-operative SICU care or those who required pre – operative 
stabilization in the SICU 
Exclusion criteria: 
1. Age less than 16 years   
2. If consent was not given by the patients’ relatives/guardians 
The study recruited consecutive patients who met the inclusion criteria 
from January to October 2010 after informed consent was obtained 
from their legally acceptable guardian. The protocol received approval 
from the Institutional Review Board of Christian Medical College, 
Vellore and was funded by the fluid research fund of the Christian 
Medical College. 
An initial blood sugar level was checked by the nurses using 
Accucheck hand held point of care glucometers. The HbA1C sample 
was collected from all trauma patients admitted to SICU within 24 
hours of admission to the hospital. The blood sample was sent to the 
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department of biochemistry for analysis using high performance liquid 
chromatography method. High-performance liquid chromatography 
(HPLC) is a form of liquid chromatography to separate compounds that 
are dissolved in solution. The charge difference between haemoglobin 
A0 and HbA1c has been widely utilized to separate these two fractions, 
by the ion-exchange high-performance liquid chromatography system. 
The ion exchange high pressure liquid chromatography (HPLC) also 
allows the detection of the most common haemoglobin variants. HPLC 
instruments consist of a reservoir of mobile phase, a pump, an injector, 
a separation column, and a detector. Compounds are separated by 
injecting a plug of the sample mixture onto the column. The different 
components in the mixture pass through the column at different rates 
due to differences in their partitioning behaviour between the mobile 
liquid phase and the stationary phase.  
At admission, Acute Physiology and Chronic Health Evaluation II 
(APACHE II) scores, Injury Severity Score and demographic 
information were collected using the case report form appended in 
Appendix 3. Patient’s relatives were questioned for further information 
about the patient such as other comorbidities including hypertension, 
obesity, chronic obstructive airway diseases and coronary heart 
disease. Details of the circumstances leading to the injury were also 
 Page | 40  
 
sought. A description of each injury in addition to the injury severity 
score was obtained to grade the grievousness of the injury.  
The patients were followed up from the time of admission to the SICU 
till discharge from the SICU for the incidence of hospital acquired 
infections (HAI), the number of ventilated days, number of days of 
central venous access, the duration and outcome of stay in the SICU 
and mortality. The treating physician in SICU who was blinded to the 
HBA1C levels in the subject assessed outcomes and potential effect 
modifiers such as APACHE II and Injury Severity Score. The National 
Nosocomial Infections Surveillance System (NNIS) criteria from the 
Centers of Disease Control were used for the diagnosis of HAI. Death 
and “Discharge Against Medical Advice” (DAMA) were considered 
poor outcomes. When the study was designed, HBA1C of 6.0 or 
greater was considered high and those less than 6.0 were categorized 
as normal. Supplementary analysis has been included to reflect recent 
ADA recommendations of 2010.(8)  
Sample size:  
A one sided test to detect with 80% power and an alpha error of 5% a 
30% prevalence of poor outcomes in trauma patients with diabetes as 
compared to 10% poor outcomes in non-diabetic trauma patients will 
require 58 subjects in each arm. Expecting one third of patients to have 
HBA1C greater than 6%, we chose a ratio of 1:3 elevated HBA1C to 
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normal HBA1C. The study sought to recruit 40 subjects with elevated 
HBA1C and 120 subjects with normal HBA1C within a consecutive 
cohort of 160 subjects. The study was censored at 120 subjects in 
order to meet the deadline for submission of thesis.  
Statistical methods:  
The primary analysis used a binary logistic regression to estimate risk 
for poor outcomes between those with high and low HBA1C groups 
(>=6 or <6) adjusted for APACHE II score, injury severity score, 
admission blood sugars and age. Risk estimates were provided with 
exact p values and a 95% CI of the odds ratio. Univariate analysis used 
appropriate tests of significance (independent samples T test for 
normally distributed continuous variables and Pearson’s χ2 or Fishers 
exact test for categorical variables). Secondary analysis included 
estimates of association between diabetic status, APACHE II scores, 
comorbidities and the incidence of HAI, number of ventilated days and 
number of SICU days. Exploratory analysis of these relationships at 
different levels of admission blood sugars were also carried out in a 
hypothesis generation exercise. Statistical analysis was done with 
STATA 11 (StataCorp, Texas USA).  
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One hundred and twenty trauma patients requiring admission to SICU 
between January and October 2010 were recruited. Male patients 
108/120 (90%) dominated SICU admissions for trauma. The age at 
admission ranged from 16 to 75 with a mean of 36 years (SD 15yrs). 
The mean APACHE II was 9.8 (SD 6.9) and the mean Injury Severity 
scores was 17.2 (SD 7.1). The mean HbA1C was 5.8% (SD 1.0). The 
mean admission blood sugar was 180.3 mg/dl (SD 102.1). Admission 
RBS was not available in seven of the patients.  The right skewed 
distribution of admission RBS is shown in figure 2 
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Twenty-six of the 113 patients (23%) with a Random Blood Sugar 
(RBS) measurement at admission had hyperglycaemia of greater than 
200 mg/dL. Eleven of the patients had a pre-trauma diagnosis of 
diabetes. These and other key baseline parameters are presented in 
table 5 below. 
HbA1C 
Low (<6) 
n = 91 
High (>=6) 
n = 29 
Gender 
Female 7 (58%) 5 (42%) 
Male 84 (78%) 24 (22%) 
RBS* 
200 or more 13  13  
Less than 200 71  16  
History of 
Diabetes 
Yes 2 (18%) 9 (82%) 
No 89 (82%) 20 (18%) 
AGE (years) Mean 34.3 42.7 
APACHE II Mean 9.2 11.7 
Inj. Sev. Score  Mean 17.8 15.5 
Table 5- Baseline data 
* Admission RBS was available for 113 participants 
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Younger patients (<35 years) had a significantly better outcome to ICU 
stay as compared to the older people (1.6% poor outcomes vs. 27 poor 
outcomes; p< 0.0001). Figure 3 demonstrates the poor outcomes with 
increasing age and HbA1C levels. Most adverse outcomes occurred in 
those above 35 years and most of those who had higher HBA1C levels 
were in the older age groups.  
 
Figure 3 - Scatter plot of Age at event and HBA1C
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One hundred and seventeen admissions (97.5%) were a result of blunt 
trauma and the rest due to penetrating injuries. The common causes of 
blunt trauma were road traffic injuries (98/117) or fall from heights 
especially into unprotected wells (8/117).   
Fig
ure 4 – Description of Injuries 
 
The duration of ICU stay ranged between 1 and 39 days with a mean 
of 9.5 days (SD 7.6). Ninety-nine of the 120 participants (83%) required 
ventilation and the mean duration of ventilation was 7.6 days (SD 6.4). 
65 participants (54%) developed hospital acquired infections as 
defined in the NNIS criteria.  
Of those ventilated, 39 (39.4%) developed Ventilator Associated 
Pneumonia (VAP).  Thirty one participants developed surgical site 
infection, 15 urinary tract infection and 18 catheter related blood stream 
infection. 
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      Classification of infection N =120 
HAI 65 (54%) 
VAP 39 (39.4%) 
SSI 31 (25.8%) 
CRBSI 18 (15%) 
UTI 15 (12.5%) 
Table 6 - Incidence of infections 
Distribution of HbA1C in the study group: 
Figure 5 below shows the distribution of HBA1C in the study population. 
Most values are clustered around 5 and 6 with the mean of 5.8% 
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Figure 5 - Distribution of HbA1C 
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Twenty nine (24%) of the120 patients had an HbA1C >= 6. Thirteen of 
84 patients (15%) with low HBA1C had admission blood glucose levels 
above 200 mg/dL while 13 of 29 patients (45%) with high HBA1C had 
admission sugars above 200 mg/dL. The relationship between 
admission RBS and HbA1C is shown in figure 6 below. 
 
 
Figure 6 - Comparison of HBA1C and admission RBS 
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SUBANALYSIS: 
Classifying by the 2010 ADA criteria, 67(56%) had HbA1C <5.7, 39 
(32%) an HbA1C between 5.7 and 6.4 and 14(12%) an HbA1C 6.5 and 
above. According ADA 2010 standards of clinical management of 
diabetes these represent people who do not have diabetes, those at 
risk and those with diabetes respectively. The pie diagram in figure 7 
shows the relative proportions of HbA1C across ADA 2010 categories. 
 
n = 120 
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Figure 7 - Distribution of patients by HBA1C Categories 
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Six of 17 patients (35%) who met the 2010 ADA criteria for diagnosis of 
diabetes (The 17 included those with HbA1C ≥ 6.5 or were on 
treatment for diabetes) were previously undiagnosed to be diabetic. Of 
the eleven patients who had a pre-trauma diagnosis of diabetes, 2 had 
an HbA1C of < 6%, one person had an HbA1C level between 6 & 6.5% 
and 8 had more than 6.5%. The figure 8 shows the distribution of 
diabetics across their current HbA1C levels.  
 
Figure 8 - Distribution of HBA1C amongst diabetics 
 
Five out of the 11 patients who had a pre-admission diagnosis of 
diabetes and 2 of the 6 newly diagnosed diabetics had HbA1C greater 
than 7% which is considered the sub-optimal glycaemic control. 
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HbA1C and ICU outcomes: 
In the unadjusted analysis, those with HBA1C >= 6 had 3.14 times 
greater risk of poor outcome at the end of hospital stay as compared to 
those with HBA1C <6 (95% CI 1.29 to 7.61; P = 0.02).  
 
Figure 9 - HBA1C and ICU outcomes 
When we classified HBA1C by ADA 2010 guidelines, we noticed a 
trend of increasing risk for poor outcomes across the normal, at risk 
group and diabetics as shown in figure 10.  
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Figure 10 - HBA1C (ADA 2010) and outcomes 
 
We observed a trend of increasing risk of poor outcomes with 
increasing HBA1C and that in non-diabetics, higher admission RBS 
implied higher risk of poor outcome, however the trend reverses in the 
diabetic group as illustrated in the graph in figure 11. 
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Figure 11 - Outcome across HBA1C categories stratified by 
admission RBS 
 
Those with HbA1C >= 6 also showed a prolongation of ICU stay (1.5 
days p-0.38), increased number of ventilated days (2.1 days; p0.16), 
ventilator associated pneumonia (RR 1.23; p-0.5) and higher risk for 
bloodstream infections (RR 1.16; p-0.37). This is depicted in the graphs 
in figure 12 and 13. Sixty five (54%) of the participants developed 
Hospital Acquired Infections. Twelve of 17 diabetics (70%) and 53 of 
103 (52%) non-diabetics developed HAI. ICU stay and ventilated days 
were greater for those with higher HBA1C however the difference was 
not statistically significant. 
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 HBA1C < 6 
(n=91) 
HBA1C >= 6 
(n=29) 
P Value 
H A I 49 (54%) 16 (55%) 0.901 
VAP 28 (31%) 11 (38%) 0.473 
Ventilated days [Mean] 7.12  9.21 0.161 
ICU stay (days) [Mean] 10.3 11.8  0.387 
Poor outcome 8 (9%) 8(28%) 0.010 
Table 7- HBA1C and key outcomes measures 
The mean duration of ICU admission, number of ventilated days and 
incidence of HAI and VAP are tabulated in table 8 using the ADA 2010 
cut-offs. 
 
The increasing risk of HAI and VAP with increasing HBA1C levels is 
depicted in the graph (figure 12) below.  
Table 8 - HBA1C by ADA 2010 criteria and key outcome measures 
HBA1C < 5.7 
(n=67) 
5.7– 6.4 
(n=39) 
>= 6.5 
(n=14) 
P value 
Hospital Acquired Infection 36 (54%) 20(51%) 9 (64%) 0.70 
VAP 27 (30%) 14(36%) 5 (36%) 0.78 
Ventilated days [Mean (SD)] 7.3 (6.0) 7.4 (7.2) 10 (6.2) 0.43 
ICU stay (days) [Mean (SD)] 10 (6.9) 11.1 (9.1) 12.9 (8.7) 0.55 
Poor outcome 6 (9%) 6(15%) 4(29%) 0.13 
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Figure 12 - Incidence of VAP / HAI across HBA1C levels 
Similarly number of ventilated days and ICU days increased with 
HBA1C levels as illustrated in figure 13 below.  
 Figure 13 - Mean ventilated days / ICU stay across HBA1C levels 
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The predictors of poor outcome to ICU stay were age, APACHE II 
HBA1C and history of diabetes. The univariate analysis of the 
predictors is presented in table 9.  
Parameter 
Good 
outcome Poor outcome P value 
Number (N) 104 16 
Age (Mean) 34.5 48.25 0.001 
APACHE II (Mean) 9 15.1 0.02 
Injury Severity (Mean) 17.3 16.9 0.87 
Initial RBS >=200 22(22%) 4(27%) 0.744 
HBA1C >=6% 21(20%) 8(50%) 0.01 
Diabetes N (%) 12(11.5%) 5(31.3%) 0.035 
V A P   N (%) 28(26.9%) 11(69%) 0.001 
Blood stream N (%) 15(14.4%) 3(18.8%) 0.652 
UTI N (%) 14(13.5%) 1(6.3%) 0.417 
SSI N (%) 25 (24.1%) 6(37.5%) 0.252 
 
Table 9 - Predictors of poor outcomes 
In order to predict the risk of developing a poor outcome in those with 
HBA1C >=6 a logistic model was developed which adjusted for 
APACHE II score, Injury severity score, baseline random blood sugar 
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and age at admission. In this model, those with HBA1C >=6 had a 4.57 
times greater risk of poor outcome than those with HBA1C <6 (95% CI 
1.1 to 18.9). Age and APACHE II scores were the other important 
predictors of ICU stay. The parameters used in the model are shown in 
table 10. 
 Odds Ratio P value (95% CI) 
Age 1.06 0.01 (1.02 1.11) 
HBA1C ≥ 6% 4.57 0.04 (1.11 18.88) 
Admission RBS 0.99 0.14 (0.99 1.00) 
APACHE II 1.08 0.08 (0.99 1.17) 
Injury Severity 1.04 0.39 (0.95 1.14) 
Table 10 - Adjusted OR for predictors of poor outcomes 
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Discussion
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Blood sugar control in intensive care settings has seen paradigm shifts 
over the years. While several large studies have conclusively 
demonstrated the association between hyperglycaemia and adverse 
ICU outcomes, (7, 12, 17) it is only in the recent past that literature has 
been forthcoming in the context of trauma related admissions. (60) 
There is however, considerable debate on whether the relationship is 
causal or confounded and how tight the control of blood sugar needs to 
be. Stress hyperglycaemia is defined as a transient plasma glucose 
level above 200 mg/dL.(8) It is postulated that increased levels of 
cortisol, glucagon, and epinephrine as a consequence of derangement 
of a finely tuned neuroendocrine homeostasis is responsible for the 
elevated blood sugars.(7, 12) The magnitude of stress response is 
proportional to the magnitude of tissue trauma (7).  
Kopelman et al found the prevalence of abnormal HBA1C in trauma 
patients to be 22%. (21) In our study we found that 24.2% of our 
patients had a similarly abnormal HBA1C of >= 6%. Those with higher 
HBA1C had higher incidence of adverse outcomes to ICU stay as 
shown in table 7. This study suggests that HBA1C might be a more 
useful predictor of ICU outcomes than admission blood sugars in 
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trauma patients with an adjusted OR of 4.5 as compared to 0.99 for 
admission RBS (table 10).  
This cohort of trauma patients were predominantly male (90%) and this 
possibly reflects the risk of trauma in the community and health 
seeking characteristics of the populations. Other studies have also had 
higher proportion of patients being male.(60) The mean APACHE II 
scores of 9.8 and the mean ISS of 17 suggests that the severity of 
injuries in this cohort were less severe than those in western cohorts 
which usually result from higher velocity blunt trauma. (60) 
Despite the lower mean age in this cohort, we found 9% of the patients 
had a pre-trauma diagnosis of diabetes. In addition, using HBA1C and 
the ADA 2010 criteria, we identified six additional diabetic individuals 
indicating that 14.1% of this cohort were diabetic. A further 38 
individuals (32%) had an HbA1C between 5.7 and 6.4 classified by 
ADA as at risk for diabetes mellitus. The high prevalence of diabetes is 
consistent with recent observations from community based cohorts that 
estimate the prevalence of diabetes in those above 20 years of age to 
be as high as 15%.(1) 
Age at admission is a strong predictor of ICU outcomes with all but one 
poor outcomes occurring in those more than 35 years. APACHE II 
scores unsurprisingly predicted the outcomes well. Like a few recent 
studies we also noticed that the ISS when adjusting for other risk 
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factors such as age, obesity, APACHE II and HbA1C was a poor 
predictor of ICU outcome.(12, 60) This poor discrimination may be a 
consequence of the lack of spread of ISS values with most of our 
patients having lower Injury severity scores. The mean admission RBS 
value of 180 mg/dl is higher than those observed in cohorts of trauma 
patients in other studies. (9, 60) HbA1C was an independent predictor 
of ICU outcome after adjusting for age, admission blood sugar, 
APACHE II and Injury Severity Score (table 10). Higher HBA1C was 
also associated with increase in mean duration of ICU stay and mean 
number of ventilated days, and the incidence of HAIs though these 
relationships were not statistically significant which might be due to an 
inadequate sample size for secondary outcomes (table 7 & 8).  
In an interesting ambispective cohort study, (19) Brian B. Graham et al, 
analyse two large patient datasets from the University HealthSystem 
Consortium and Mayo Clinic APACHEIII database and conclude that 
Diabetes may not be an independent risk factor and suggest that it 
might be a protective factor in medical ICU settings. In contrast this 
study shows an unambiguous trend on increased mortality for those 
with diabetes in trauma related ICU care. 
In our study the admission RBS of ≥ 200 mg/dL is associated with 
adverse outcomes though not significant statistically. Higher admission 
RBS while a risk factor amongst those without diabetes(RR 1.25) 
 Page | 64  
 
appears to be protective for those with diabetes (RR 0.47) and 
suggests a qualitative interaction between diabetic status and 
admission RBS in terms of ICU outcome though the association was 
not statistically significant. It is postulated the stress induced 
hyperglycaemia is a greater risk factor amongst non-diabetics as 
compared to diabetics. (18, 19, 61) It must be noted that this study only 
documented initial blood sugars at admission and did not measure 
fluctuations of sugar or the effects of the insulin therapy and therefore 
may be incomplete in representing the complex and still poorly 
understood relationship between hyperglycaemia, HBA1C and ICU 
outcome.  
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This cohort study of trauma patients admitted to Surgical ICU 
examined the relationship between HBA1C and the outcomes of ICU 
stay.  
1. The prevalence of HBA1C ≥ 6% in this study was 24.2% and 
these individuals would be either diabetic or at risk of developing 
diabetes.  
2. Six out of 17 diabetic patients (35%) did not know that they were 
diabetic at admission. 5.5% (6/109) of this cohort has occult 
diabetes mellitus.  
3. There was a 3.14 times greater risk of poor outcomes in those 
with HBA1C ≥ 6% or above as compared to those with HBA1C < 
6%. This association strengthened on adjusting for admission 
blood sugars, APACHE II, ISS to an odds ratio of 4.6. 
4. Those with elevated HBA1C (>=6%) had, on average, 2.1 days 
more of ventilation and 1.5 days longer ICU admission.  
5. Sixty five (54%) of the participants developed Hospital Acquired 
Infections with similar proportions in those with normal and 
elevated HBA1C.  
6. That 14.2% of the adults were diabetic and that 35% of these 
diabetic individuals were undiagnosed before admission 
combined with the increased risk of poor outcomes among those 
 Page | 67  
 
with higher HBA1C suggests screening for diabetes may be 
useful in managing patients in ICU settings. 
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Limitations
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The small sample size, while adequate to assess the primary outcome 
was insufficient to address secondary objectives like HAI and number 
of ventilated days. We did not measure how well the sugars were 
controlled or quantify the duration of hyperglycemia or the number of 
hypoglycaemic episodes which could confound the association. The 
quantum of blood transfusion in those who did not have their HBA1C 
sample drawn prior to transfusion was not documented. This might 
have falsely lowered the values as diabetics are not permitted to 
donate blood.  
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APPENDIX 1: APACHE II SCORE 
Apache II was scoring system developed by Knaus W A to classify the severity of disease among patients 
admitted in critical care settings. The following twelve physiological measurements along with age and previous 
health status are used to provide a general measure of severity of disease: 
Heart Rate (bpm) Score 
≤ 39 4 
40 – 54 3 
55 – 69 2 
70 – 109 0 
110 – 139 2 
140 – 179 3 
≥ 180 4 
Respiratory Rate (/min) Score 
≤ 5 4 
6 – 9 2 
10 –11 1 
12 – 24 0 
25 – 34 1 
35 – 49 3 
≥ 50 4 
If FiO2 ≥ 0.5  
(A-a)O2  mm Hg Score 
< 200  0 
200 – 349 2 
350 – 449 3 
≥ 50 4 
If FiO2 < 0.5 :  
(PaO2) mm Hg Score 
< 55 4 
55 – 60 3 
61 – 70 1 
≥ 70  0 
Temperature 0C Score 
≤ 29.9 °C 4 
30 - 31.9 °C 3 
32 - 33.9 °C 2 
34 - 35.9 °C 1 
36 - 38.4 °C 0 
38.5 - 38.9 °C 1 
39 - 40.9 °C 3 
≥ 41°C 4 
Mean Arterial Pressure Score 
≤ 49 mm Hg 4 
50 - 69  mm Hg 2 
70 - 109  mm Hg 0 
110 -129  mm Hg 2 
130 - 159  mm Hg 3 
≥ 160  mm Hg 4 
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If ABG is not available 
HCO3 mmol/L Score 
≥ 52 4 
41 – 51.9 3 
32 – 40.9 1 
22 – 31.9 0 
18 – 21.9 2 
15 – 17.9 3 
≤15 4 
Arterial PH Score 
≥ 7.7 4 
7.6 – 7.69 3 
7.5 – 7.59 1 
7.33 – 7.49 0 
7.25 – 7.32 2 
7.15 – 7.24 3 
≤ 7.15 4 
Serum Na+ (mmol/L) Score 
≥ 180 4 
160 – 179 3 
155 – 159 2 
150 – 154 1 
130 – 149 0 
120 – 129 2 
111 - 119  3 
≤ 110 4 
Serum K+ (mmol/L) Score 
≥ 7 4 
6 – 6.9 3 
5.5 – 5.9 1 
3.5 – 5.4 0 
3 – 3.4 1 
2.5 – 2.9 2 
≤2.5 4 
Patient with ARF 
Se Creatinine mg/dL Score 
≤ 0.6 4 
0.6 – 1.4 0 
1.5 – 1.9 4 
2.0 – 3.4 6 
≥ 3.5 8 
Patient without ARF 
Se Creatinine mg/dL Score 
≤ 0.6 2 
0.6 – 1.4 0 
1.5 – 1.9 2 
2.0 – 3.4 3 
≥ 3.5 4 
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Haematocrit (%) Score 
≤ 20 4 
20 – 29.9 2 
30 – 45.9 0 
46 – 49.9 1 
50 – 59.9 2 
≥ 60 4 
WBC (x103 /mm3) Score 
≤ 1 4 
1 – 2.9 2 
3 – 14.9 0 
15 – 19.9 1 
20 – 39.9 2 
≥ 40 4 
GCS Score GCS Score 
15 0 8 7 
14 1 7 8 
13 2 6 9 
12 3 5 10 
11 4 4 11 
10 5 3 12 
9 6  13 
Age Score 
≤ 44 0 
45 – 54 2 
55 – 64 3 
65 – 74 5 
≥ 75 6 
Chronic Organ Insufficiency  in patients admitted for SCORE 
Postoperative – Emergency 5 
postoperative – Elective 2 
Non operative 5 
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CHRONIC ORGAN INSUFFICIENCY / IMMUNOCOMPROMISED STATE 
Liver 
insufficiency 
Cardiovascular Respiratory Renal Immuno depression 
Biopsy proven 
cirrhosis 
Documented 
portal 
hypertension, 
Episodes of 
past upper GI 
bleeding 
attributed to 
portal 
hypertension 
Prior episodes 
of hepatic 
failure / 
encephalopathy 
/ coma. 
NYHA Class IV Chronic restrictive, 
obstructive or 
vascular disease 
resulting in severe 
exercice 
restriction. 
Documented 
chronic hypoxia, 
hypercapnia, 
secondary 
polycythemia , 
severe pulmonary 
hypertension (> 40 
mmHg), or 
respirator 
dependency. 
Receiving 
chronic 
dialysis 
The patient has 
received therapy that 
suppresses resistance 
to infection 
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Appendix 2 – Glucose control protocol – SICU, CMC Vellore 
   Insulin infusion rate (unit / ml / hour) 
Plasma glucose levels 
(mg %) 
Algorithm 1 Non 
DM 
Algorithm 2  
DM,HTN, TPN  Algorithm 3  Algorithm 4 
< 50  Hypoglycaemia protocol 
50 ‐ 80  0  0  0  0 
81 ‐ 100  0.2  0.5  1  1.5 
101 ‐ 120  0.5  1  2  3 
121 ‐ 140  1  1.5  3  5 
141 ‐ 180  1.5  2  4  7 
181 ‐ 200  2  3  5  9 
201 ‐ 230  2  4  6  12 
231 ‐ 270  3  5  8  16 
271 ‐ 290  3  6  10  20 
291 ‐ 320  4  7  12  24 
321 ‐ 360  4  8  14  28 
>360  6  12  16  28 
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